tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

AstraZeneca price target raised to $97 from $93 at Berenberg
The FlyAstraZeneca price target raised to $97 from $93 at Berenberg
29m ago
AZN
AstraZeneca’s Ondexxya Study: A Closer Look at Safety and Effectiveness
PremiumCompany Announcements
AstraZeneca’s Ondexxya Study: A Closer Look at Safety and Effectiveness
4h ago
AZN
AstraZeneca’s NASH Study Completes: Market Implications of AZD4831
PremiumCompany Announcements
AstraZeneca’s NASH Study Completes: Market Implications of AZD4831
4h ago
AZN
AstraZeneca’s Latest Study on Inhaler Propellants: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Latest Study on Inhaler Propellants: Key Insights for Investors
4h ago
AZN
AstraZeneca’s Real-World Study on Dapagliflozin: A Strategic Move in Heart Failure Treatment
PremiumCompany Announcements
AstraZeneca’s Real-World Study on Dapagliflozin: A Strategic Move in Heart Failure Treatment
4h ago
AZN
AstraZeneca’s SERENA-1 Study: A Promising Development in Breast Cancer Treatment
PremiumCompany AnnouncementsAstraZeneca’s SERENA-1 Study: A Promising Development in Breast Cancer Treatment
4h ago
AZN
AstraZeneca Completes Key Study on Asthma and COPD Diagnostics
Premium
Company Announcements
AstraZeneca Completes Key Study on Asthma and COPD Diagnostics
4h ago
AZN
AstraZeneca’s New CKD Study: A Potential Game-Changer?
Premium
Company Announcements
AstraZeneca’s New CKD Study: A Potential Game-Changer?
4h ago
AZN
AstraZeneca’s Acalabrutinib Study: A Promising Update for B-cell Malignancies
PremiumCompany Announcements
AstraZeneca’s Acalabrutinib Study: A Promising Update for B-cell Malignancies
4h ago
AZN
AstraZeneca’s PRIMULA Preg Study: Evaluating Anifrolumab’s Safety During Pregnancy
PremiumCompany Announcements
AstraZeneca’s PRIMULA Preg Study: Evaluating Anifrolumab’s Safety During Pregnancy
4h ago
AZN
AstraZeneca’s SZC Study Completion: Impact on Hyperkalemia Management
PremiumCompany Announcements
AstraZeneca’s SZC Study Completion: Impact on Hyperkalemia Management
4h ago
AZN
AstraZeneca’s AZD7789 Study: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s AZD7789 Study: A Potential Game-Changer in Cancer Treatment
1d ago
AZN
Eli Lilly and AstraZeneca’s Promising Phase 3 Study on Lung Cancer Treatment
PremiumCompany AnnouncementsEli Lilly and AstraZeneca’s Promising Phase 3 Study on Lung Cancer Treatment
1d ago
AZN
LLY
AstraZeneca’s Tozorakimab Study: A New Phase in Drug Delivery
Premium
Company Announcements
AstraZeneca’s Tozorakimab Study: A New Phase in Drug Delivery
1d ago
AZN
PRXL
AstraZeneca’s DESTINY-Lung04 Study: A Potential Game-Changer in NSCLC Treatment
Premium
Company Announcements
AstraZeneca’s DESTINY-Lung04 Study: A Potential Game-Changer in NSCLC Treatment
1d ago
AZN
AstraZeneca’s SERENA-4 Study: A New Hope in Breast Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s SERENA-4 Study: A New Hope in Breast Cancer Treatment
1d ago
AZN
AstraZeneca’s Real-World Study of Koselugo: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Real-World Study of Koselugo: Key Insights for Investors
1d ago
AZN
AstraZeneca’s ATHENA Study: A New Hope for Liver Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s ATHENA Study: A New Hope for Liver Cancer Treatment
1d ago
AZN
AstraZeneca’s Phase 2 Study on TAK-341 for Multiple System Atrophy: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Phase 2 Study on TAK-341 for Multiple System Atrophy: Key Insights for Investors
1d ago
AZN
AstraZeneca’s UmbREALung Study: Real-World Insights into NSCLC Treatment
PremiumCompany AnnouncementsAstraZeneca’s UmbREALung Study: Real-World Insights into NSCLC Treatment
1d ago
AZN
Drugmakers criticize Trump drug price negotiation plan, Bloomberg reports
Premium
The Fly
Drugmakers criticize Trump drug price negotiation plan, Bloomberg reports
1d ago
AZN
BMY
Pharma cos criticize Trump’s drug price negotiation plan, Bloomberg Law reports
Premium
The Fly
Pharma cos criticize Trump’s drug price negotiation plan, Bloomberg Law reports
1d ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >